Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as $16.81 and last traded at $17.08, with a volume of 74400 shares. The stock had previously closed at $17.17.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on CCAP. Wells Fargo & Company reduced their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Friday, February 21st. Keefe, Bruyette & Woods boosted their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.20.
Get Our Latest Stock Analysis on CCAP
Crescent Capital BDC Stock Down 1.0 %
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The firm had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. Analysts forecast that Crescent Capital BDC, Inc. will post 2.09 EPS for the current year.
Crescent Capital BDC Dividend Announcement
The company also recently announced a dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a $0.05 dividend. The ex-dividend date is Friday, February 28th. Crescent Capital BDC’s payout ratio is 84.42%.
Institutional Trading of Crescent Capital BDC
Several hedge funds and other institutional investors have recently modified their holdings of CCAP. Montag A & Associates Inc. acquired a new position in Crescent Capital BDC in the 4th quarter worth about $35,000. C M Bidwell & Associates Ltd. acquired a new position in Crescent Capital BDC in the fourth quarter worth approximately $39,000. Aquatic Capital Management LLC bought a new position in Crescent Capital BDC during the fourth quarter valued at approximately $129,000. Generation Capital Management LLC acquired a new stake in Crescent Capital BDC in the fourth quarter valued at approximately $192,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Crescent Capital BDC in the fourth quarter worth approximately $218,000. Institutional investors and hedge funds own 49.46% of the company’s stock.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Recommended Stories
- Five stocks we like better than Crescent Capital BDC
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Quiet Period Expirations Explained
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Best Stocks Under $5.00
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.